Ultra-Sensitive N-Ras mutation detection kit_12,13,59,61,117,146

NRAS is a member of the RAS oncogene family and plays a role in the pathogensis in various cancers. Activating RAS mutations including KRAS, NRAS and HRAS have been found in 15-25% of human tumors and mainly in condons 12, 13, 59, 61 (1). NRAS mutation accounts for 15% of all RAS mutation and indicates relative resistance to anti-EGFR therapy (2). Medaysis NRAS Mutation Detection Kit includes the primer set used to amplify NRAS gene and the DNA quality control primers to assure concordance of the test results.